Flow Markers Flashcards
AML monocytes cell surface markers
NSE Cd11 Cd14 Cd64 Lysozyme Cd4 Cd11b Cd36
AML megakaryocytes cell surface markers
Cd41
Cd61
Cd42
AML erythroid cell surface markers
Cd235a
Precursor B Lymphoblastic Leukemia/Lymphoma
DR, CD19, CD20-/+, CD34, CD10+/-, sIg-, TdT+
May co-express myeloid Ag in t(9;22)
Infants w/CD10-,CD15+ suspect 11q23
Burkitt
DR, CD19, CD20, CD22, CD10+/-, CD34-, TdT-, sIg+ (bright)
CLL/SLL
DR, CD19, CD20 (dim), CD5, CD23, CD45, CD22-, CD10-, FMC7-, CD11c+/-, CD25+/-, sIg (dim to negative)
If bright sIg+, CD20+ suspect Trisomy 12
B Prolymphocytic Leukemia
DR, CD19, CD20 (bright), CD22, CD5-, CD23-, CD10-, sIg+ (bright)
Mantle Cell Lymphoma
DR, CD19, CD20, CD5, CD22, sIg+, CD43, CD23-, CD10-
Follicular Lymphoma
DR, CD19, CD20, CD10, CD22, CD5-, CD23+/-, CD11c-, CD43-, sIg+ (bright)
20% of cases are CD10-
Marginal Zone Lymphoma
DR, CD19, CD20, CD22, CD11c, sIg+, CD43+/-, CD5-, CD23-, CD10-, CD25-, CD103-
sIgD rare
Splenic Marginal Zone Lymphoma
DR, CD19, CD20, CD22, CD11c, sIg+, CD43-, CD5-, CD23-, CD10-, CD25-
sIgD+
Lymphoplasmacytic Lymphoma
DR, CD19, CD20, CD22, sIg+, CD43+/-, CD5-, CD10-, CD23-
Hairy Cell Leukemia
DR, CD19, CD20 (bright), CD22, CD25, sIg+, CD11c (bright), CD103, CD5-, CD10-, CD23-
Plasma Cell Myeloma
CD45, CD38 (bright), cIg+, sIg+/-, DR-, CD19-, CD20-, CD22-
CD56 often
Precursor T Lymphoblastic Leukemia/Lymphoma
cCD3, CD4, CD8, TdT, CD10-/+
May co-express multiple myeloid Ag
T Prolymphocytic Leukemia
CD2, CD3, CD5, CD7, CD4+/-, CD8-/+
Dual CD4+/CD8+ or CD4-/CD8+ rare
MF/SS
CD2, CD3, CD5, CD4, CD7-/+, CD8-, CD25-
May have no aberrant phenotype
Adult T-Cell Leukemia/Lymphoma
CD2, CD3, CD5, CD4, DR, CD25 (bright), CD7-, CD8-